France· FR:69491847
ETHINYLESTRADIOL/LEVONORGESTREL MAJORELLE 20 microgrammes/100 microgrammes, comprimé pelliculé
A medicinal product containing lévonorgestrel + éthinylestradiol, registered in France by LABORATOIRES MAJORELLE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- LÉVONORGESTREL + ÉTHINYLESTRADIOL
- Manufacturer
- LABORATOIRES MAJORELLE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009391080873 plaquette(s) aluminium PVC PVDC avec calendrier de 21 comprimé(s)EUR 3.76
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lévonorgestrel + éthinylestradiol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyAsumate 20Exeltis Germany Gmbh
- SwitzerlandEffilevo 0.10 mg / 0.02 mg, comprimés pelliculésEFFIK SA
- SpainAILEVA 0,1 MG/0,02 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGLaboratorios Cinfa S.A.
- CzechiaASUMATEExeltis Czech s.r.o., Praha
- United KingdomAmbelina 150microgram/30microgram tabletsCrescent Pharma Ltd
- NetherlandsEthinylestradiol/Levonorgestrel 0,02 mg/0,10 mg Focus, filmomhulde tablettenFocus Care Pharmaceuticals B.V.
- CanadaALESSE 21PFIZER CANADA ULC
- FinlandAnyaWyeth Lederle Nordiska Ab
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Erlidona, Ethinylestradiol/Levonorgestrel Nextpharma
- Belgium · Eleonor 20, Lavinia
- Bulgaria · Три-Регол
- Czechia · Ebelya, Minisiston
- Germany · Asumate 20, Asumate 30
- Denmark · Anastrella, Femicept
- Spain · Aileva, Anaomi
- United Kingdom (Northern Ireland) · Ambelina, Elevin
- Croatia · Adexa
- Hungary · Rigevidon, Seasonique
- Ireland · Leonore, Levonorgestrel/ Ethinylestradiol Renata Pharmaceuticals (Ireland)
- Iceland · Levoethin, Melleva
- Italy · Egogyn, Lasca
- Lithuania · Rigevidon, Tri - Regol
- Luxembourg · Levorichter 30, Lowette
- Latvia · Rigevidon
- Netherlands · Ethinylestradiol/Levonorgestrel Ceres Pharma, Ethinylestradiol/Levonorgestrel Focus
- Norway · Melleva, Microgynon
- Poland · Levomine, Levomine Mini
- Portugal · Effilevo, Etinilestradiol + Levonorgestrel Generis
- Romania · Microgynon, Seasonique
- Sweden · Anastrella, Leverette 21
- Slovenia · Stediril-M
- Slovakia · Ebelya, Seasonique
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2acd93c-c62b-4b12-8efe-23461f6cc1f1 GET /v1/drugs/d2acd93c-c62b-4b12-8efe-23461f6cc1f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69491847",
"date_amm": "2010-06-08",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "LÉVONORGESTREL + ÉTHINYLESTRADIOL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about lévonorgestrel + éthinylestradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.